Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2021

Nagirnaja L, Mørup N, Nielsen JE, Stakaitis R, Golubickaite I, Oud MS, et al. Variant , Defective piRNA Processing, and Azoospermia. N Engl J Med. 2021;385(8):707-719.

Schwartz DA, Levitan D. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infecting Pregnant Women and the Fetus, Intrauterine Transmission, and Placental Pathology During the Coronavirus Disease 2019 (COVID-19) Pandemic: It's Complicated. Arch Pathol Lab Med. 2021;145(8):925-928.

Magro CM, Mulvey J, Kubiak J, Mikhail S, Suster D, A Crowson N, et al. Severe COVID-19: A multifaceted viral vasculopathy syndrome. Ann Diagn Pathol. 2021;50:151645.

Tabbo F, Guerrera F, van den Berg A, Gaudiano M, Maletta F, Bessone L, et al. Kinomic profiling of tumour xenografts derived from patients with non-small cell lung cancer confirms their fidelity and reveals potentially actionable pathways. Eur J Cancer. 2021;144:17-30.

Greenblatt MB, Debnath S. A stem-cell basis for skeletal ageing. Nature. 2021;597(7875):182-183.

Rendeiro AF, Ravichandran H, Bram Y, Chandar V, Kim J, Meydan C, et al. The spatial landscape of lung pathology during COVID-19 progression. Nature. 2021;593(7860):564-569.

Velu P, Craney A, Ruggiero P, Sipley J, Cong L, Hissong EM, et al. Rapid Implementation of Severe Acute Respiratory Syndrome Coronavirus 2 Emergency Use Authorization RT-PCR Testing and Experience at an Academic Medical Institution. J Mol Diagn. 2021;23(2):149-158.

Magro CM, Mulvey JJ, Laurence J, Sanders S, Crowson AN, Grossman M, et al. The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series. Br J Dermatol. 2021;184(1):141-150.

Costa V, Zhao Z, Racine-Brzostek SE, Lalazar G, Yang HS. An Interesting Case of Isolated False-Reactive Hepatitis B Surface Antigen. Case Reports Hepatol. 2021;2021:9928098.

Cho C, Hilden P, Avecilla ST, Barker JN, Castro-Malaspina H, Giralt SA, et al. Combining the Disease Risk Index and Hematopoietic Cell Transplant Co-Morbidity Index provides a comprehensive prognostic model for CD34+-selected allogeneic transplantation. Adv Cell Gene Ther. 2021;4(1).